BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15681801)

  • 1. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
    Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
    Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions.
    Cole GM; Lim GP; Yang F; Teter B; Begum A; Ma Q; Harris-White ME; Frautschy SA
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():133-6. PubMed ID: 16266772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
    Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
    J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
    Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
    Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
    Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
    Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.
    Lim GP; Chu T; Yang F; Beech W; Frautschy SA; Cole GM
    J Neurosci; 2001 Nov; 21(21):8370-7. PubMed ID: 11606625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
    Cole GM; Frautschy SA
    Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
    Lim GP; Yang F; Chu T; Chen P; Beech W; Teter B; Tran T; Ubeda O; Ashe KH; Frautschy SA; Cole GM
    J Neurosci; 2000 Aug; 20(15):5709-14. PubMed ID: 10908610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs for the chemoprevention of Alzheimer's disease.
    Szekely CA; Town T; Zandi PP
    Subcell Biochem; 2007; 42():229-48. PubMed ID: 17612054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.
    Frautschy SA; Hu W; Kim P; Miller SA; Chu T; Harris-White ME; Cole GM
    Neurobiol Aging; 2001; 22(6):993-1005. PubMed ID: 11755008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
    Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
    J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
    McGeer PL; McGeer EG
    Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.